Publications of Geraldine Jacobson, MD, MPH, MBA

The impact of adjuvant therapy on survival and recurrence patterns in women with early-stage uterine carcinosarcoma: a multi-institutional study.
Guttmann DM, Li H, Sevak P, Grover S, Jacobson GM, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL.
Int J Gynecol Cancer. 2016;26(1):141-148.


Radiation exposure from diagnostic procedures in patients with newly diagnosed breast cancer.
Chaudhary LN, Knapp S, Wen S, Xiao J, Marano GD, Kurian S, Layne G, Jacobson GM, Abraham J.
J Community Support Oncol. 2015;13(1):27-29.


Optimal management of sentinel lymph node positive biopsy patients in early breast cancer.
Jacobson GM, Partin JF, Salkeni MA.
Ann Transl Med. 2015;3(7):87

PMC4430736.

Risk of radiation-induced malignancy with heterotopic ossification prophylaxis: A case-control analysis.
Sheybani A, Tennapel MJ, Lack WD, Clerkin P, Hyer DE, Sun W, Jacobson GM.
Int J Radiat Oncol Biol Phys. 2014;89(3):584-589.


Where do patients with cancer in Iowa receive radiation therapy?
Ward MM, Ullrich F, Matthews K, Rushton G, Tracy R, Goldstein MA, Bajorin DF, Kosty MP, Bruinooge SS, Hanley A, Jacobson GM, Lynch CF.
J Oncol Pract. 2014;10(1):20-25.


High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes.
Anderson JW, Xia J, Flynn RT, Modrick JM, Bhatia SK, Jacobson GM, Kim Y.
J Contemp Brachytherapy. 2013;5(2):101-109.

PMC3708151.

Extra-pleural pneumonectomy in the setting of tri-modality therapy for patients with malignant pleural mesothelioma.
Chi A, Wen S, Nguyen NP, Jacobson GM, Remick SC, Tse WW, Liao Z.
Chin J Cancer Res. 2013;25(2):128-129.

PMC3626973.

Randomized trial of pentoxifylline and Vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by Tissue Compliance Meter.
Jacobson GM, Bhatia S, Smith BJ, Button AM, Bodeker K, Buatti J.
Int J Radiat Oncol Biol Phys. 2013;85(3):604-608.


Detection of axillary lymph node metastases and extra-axillary metastases with FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.
Jacobson GM, Marano GD, Hazard HW, Abraham J.
Pract Radiat Oncol. 2013;3(2 Suppl 1):S24-S25.


The dosimetric impact of vaginal balloon-packing on intracavitary high-dose-rate brachytherapy for gynecological cancer.
Rockey WM, Bhatia SK, Jacobson GM, Kim Y.
J Contemp Brachytherapy. 2013;5(1):17-22.

PMC3635049.

Aspirin and warfarin are associated with improved overall survival in medically inoperable endometrial cancer patients treated with radiation therapy.
Fornalik H, Goodheart M, Buekers T, DeGeest K, Jacobson GM.
Gynecol Obstetric. 2012;S4:002


The dosimetric impact of heterogeneity corrections in high-dose rate (192)Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans.
Hyer DE, Sheybani A, Jacobson GM, Kim Y.
Brachytherapy. 2012;11(6):515-520.


Image-based treatment planning of the post-lumpectomy breast utilizing CT and 3TMRI.
Jacobson GM, Zamba G, Betts V, Muruganandham M, Buechler-Price J.
Int J Breast Cancer. 2011;2011:246265

PMC3262557.

Angiosarcoma following MammoSite partial breast irradiation.
Andrews S, Wilcoxon R, Benda J, Jacobson GM.
Breast Cancer Res Treat. 2010;124(1):279-282.


Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress.
Hadzic T, ykin-Burns N, Zhu Y, Coleman MC, Leick K, Jacobson GM, Spitz DR.
Free Radic Biol Med. 2010;48(8):1024-1033.

PMC2843822.

Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach.
Lutgendorf SK, Mullen-Houser E, Russell D, DeGeest K, Jacobson GM, Hart L, Bender D, Anderson B, Buekers TE, Goodheart MJ, Antoni MH, Sood AK, Lubaroff DM.
Brain Behav Immun. 2010;24(8):1231-1240.

PMC3010350.

When is standard treatment sufficiently active to make use of a placebo-controlled trial unethical?
Grunwald HW, Storm CD, Jacobson GM.
J Oncol Pract. 2009;5(2):74-75.

PMC2790645.

Ethical issues related to patient use of complementary and alternative medicine.
Jacobson GM, Cain JM.
J Oncol Pract. 2009;5(3):124-126.

PMC2790681.

Thromboembolic events in patients with cervical carcinoma: Incidence and effect on survival.
Jacobson GM, Lammli J, Zamba G, Hua L, Goodheart MJ.
Gynecol Oncol. 2009;113(2):240-244.


Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity.
Goodheart M, Jacobson GM, Smith BJ, Zhou L.
Int J Gynecol Cancer. 2008;18(1):95-103.


Change in volume of lumpectomy cavity during external-beam irradiation of the intact breast.
Jacobson GM, Betts V, Smith B.
Int J Radiat Oncol Biol Phys. 2006;65(4):1161-1164.


Relationship between venous thromboembolism and vascular endothelial growth factor in cancer.
Jacobson GM.
Support Cancer Ther. 2005;3(1):35


Thromboembolic events in patients treated with definitive chemotherapy and radiation therapy for invasive cervical cancer.
Jacobson GM, Kamath RS, Smith BJ, Goodheart MJ.
Gynecol Oncol. 2005;96(2):470-474.


Treatment planning optimization using constrained simulated annealing.
Morrill SM, Lane RG, Jacobson GM, Rosen II.
Phys Med Biol. 1991;36(10):1341-1361.


Electron arc therapy: chest wall irradiation of breast cancer patients.
McNeely LK, Jacobson GM, Leavitt DD, Stewart JR.
Int J Radiat Oncol Biol Phys. 1988;14(6):1287-1294.


Postoperative radiation therapy for pathologic stage C prostate cancer.
Jacobson GM, Smith JA, Jr., Stewart JR.
Int J Radiat Oncol Biol Phys. 1987;13(7):1021-1024.


Breast irradiation following silicone gel implants.
Jacobson GM, Sause WT, Thomson JW, Plenk HP.
Int J Radiat Oncol Biol Phys. 1986;12(5):835-838.


Dose response analysis of pediatric neuroblastoma to megavoltage radiation.
Jacobson GM, Sause WT, O'Brien RT.
Am J Clin Oncol. 1984;7(6):693-697.